**4. Conclusions**

Peptide receptor radionuclide therapy is an innovative treatment approach for meningiomas, with a large and untapped potential.

**Author Contributions:** Conceptualization: C.-K.F. and F.B.; writing and original draft preparation: C.-K.F., S.G.C.-V. and F.B.; writing, review and editing: C.-K.F., J.S., J.H., S.G.C.-V. and F.B. All authors have read and agreed to the published version of the manuscript.

**Funding:** This research received no external funding. We acknowledge support by the Open Access Publishing Fund of the University of Tübingen.

**Data Availability Statement:** Not applicable.

**Conflicts of Interest:** The authors declare no conflict of interest.
